ChemicalBook > CAS DataBase List > Indusatumab
Indusatumab
- Product Name
- Indusatumab
- CAS No.
- 1497400-26-6
- Chemical Name
- Indusatumab
- Synonyms
- Indusatumab;Indusatumab (anti-GUCY2C);Research Grade Indusatumab;Research Grade Indusatumab(DHD65601)
- CBNumber
- CB88080934
- Formula Weight
- 0
- MOL File
- Mol file
More
Less
Indusatumab Property
- form
- Liquid
- color
- Colorless to light yellow
More
Less
Indusatumab Chemical Properties,Usage,Production
Uses
Indusatumab (5F9 Monoclonal antibody) is an anti-human GUCY2C (Guanylate cyclase 2C) monoclonal antibody[1].
References
[1] e Goeij BE, et al. New developments for antibody-drug conjugate-based therapeutic approaches. Curr Opin Immunol. 2016 Jun;40:14-23. DOI:10.1016/j.coi.2016.02.008
Indusatumab Preparation Products And Raw materials
Raw materials
Preparation Products
More
Less
Indusatumab Suppliers
- Tel
- 021-61312847; 18021002903
- Fax
- QQ:3008007432
- 3008007409@qq.com
- Country
- China
- ProdList
- 71826
- Advantage
- 60
- Tel
- 177-54423994 17754423994
- Fax
- QQ:2853530913
- 2853530910@QQ.com
- Country
- China
- ProdList
- 8000
- Advantage
- 62
- Tel
- 027-65317797 15926423062
- Fax
- QQ:422450190
- 422450190@qq.com
- Country
- China
- ProdList
- 10308
- Advantage
- 58
- Tel
- 4008200310
- marketing@tsbiochem.com
- Country
- China
- ProdList
- 24961
- Advantage
- 58
- Tel
- 027-65279366 18108604356
- products@biolabreagent.com
- Country
- China
- ProdList
- 9868
- Advantage
- 58
- Tel
- 13720134139 086-15871494362 13720134139
- orders@jknbiochem.com
- Country
- China
- ProdList
- 6762
- Advantage
- 58
- Tel
- 021-65675885 18964387627
- customer_service@efebio.com
- Country
- China
- ProdList
- 11973
- Advantage
- 58
- Tel
- 400-6206333 13167063860
- anhua.mao@aladdin-e.com
- Country
- China
- ProdList
- 48457
- Advantage
- 58
- Tel
- 0731-13823398 15111215862
- 313359644@qq.com
- Country
- China
- ProdList
- 4161
- Advantage
- 58
- Tel
- 027-87008169 17762441161
- info@atagenix.com
- Country
- China
- ProdList
- 10001
- Advantage
- 58
1497400-26-6, IndusatumabRelated Search:
Andecaliximab
Canakinumab
Landogrozumab
Gantenerumab
Avelumab
Codrituzumab
Blosozumab
Clazakizumab
Rilotumumab
Brontictuzumab